SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Dollar David Christopher

(Last) (First) (Middle)
7 CUSTOM HOUSE STREET

(Street)
PORTLAND ME 04101

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/07/2019
3. Issuer Name and Ticker or Trading Symbol
COVETRUS, INC. [ CVET ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 685(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Received in the pro rata distribution of shares of common stock of Covetrus, Inc. ("Covetrus") owned by Henry Schein, Inc. ("Henry Schein") to the stockholders of Henry Schein in connection with the spin-off of the Henry Schein Animal Health Business into Covetrus, pursuant to the Contribution and Distribution Agreement, dated as of April 20, 2018, as amended, by and among Henry Schein, Covetrus, Direct Vet Marketing, Inc. (d/b/a Vets First Choice) ("Vets First Choice"), and Shareholder Representative Services LLC, solely in its capacity as the representative of the Vets First Choice stockholders and for the purposes of certain articles set forth therein.
Remarks:
Exhibit List Exhibit 24 - Power of Attorney Senior Vice President and President, Global Software Services
/s/ Erin Powers Brennan, as attorney-in-fact for David Christopher Dollar 02/19/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
                                                                      EXHIBIT 24

                           LIMITED POWER OF ATTORNEY FOR

                           SECTION 16 REPORTING PURPOSES

    KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and
appoints each of Christine Komola and Erin Powers Brennan, signing singly, as
his or her true and lawful attorney-in-fact to:

        (1)  execute for and on behalf of the undersigned, in the undersigned's
    capacity as an officer of Covetrus, Inc. (the "Company"), Forms 3, 4, and 5
    in accordance with Section 16(a) of the Securities Exchange Act of 1934, as
    amended (the "Exchange Act") and the rules and regulations promulgated
    thereunder and any other forms or reports the undersigned may be required to
    file in connection with the undersigned's ownership, acquisition, or
    disposition of securities of the Company;

        (2)  seek or obtain, as the undersigned's representative and on the
    undersigned's behalf, information on transactions in the Company's
    securities from any third party, including brokers, employee benefit plan
    administrators and trustees, and the undersigned hereby authorizes any such
    person to release any such information to any attorney-in-fact and further
    approves and ratifies any such release of information;

        (3)  do and perform any and all acts for and on behalf of the
    undersigned which may be necessary or desirable to complete and execute any
    such Form 3, 4, or 5, or other form or report, and timely file such form or
    report with the U.S. Securities and Exchange Commission and any stock
    exchange or similar authority; and

        (3)  take any other action of any type whatsoever in connection with the
    foregoing which, in the opinion of such attorney-in-fact, may be of benefit
    to, in the best interest of, or legally required by, the undersigned, it
    being understood that the documents executed by such attorney-in-fact on
    behalf of the undersigned, pursuant to this Limited Power of Attorney, shall
    be in such form and shall contain such terms and conditions as such
    attorney-in-fact may approve in his or her discretion.

    The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform each and every act and thing whatsoever requisite,
necessary, and proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or his
substitute or substitutes, shall lawfully do or cause to be done by virtue of
this Limited Power of Attorney and the rights and powers herein granted.

    The undersigned hereby acknowledges that (a) the foregoing attorneys-in-fact
are serving in such capacity at the request of the undersigned; (b) this Limited
Power of Attorney authorizes, but does not require, each such attorney-in-fact
to act in his or her discretion on information provided to such attorney-in-fact
without independent verification of such information; (c) any documents
prepared and/or executed by any attorney-in-fact on behalf of the undersigned
pursuant to this Limited Power of Attorney shall be in such form and shall
contain such information and disclosure as such attorney-in-fact, in his or her
sole discretion, deems necessary or advisable; (d) neither the Company nor any
attorney-in-fact assumes (i) any liability for the undersigned's responsibility
to comply with the requirements of the Exchange Act, (ii) any liability of the
undersigned for any failure to comply with such requirements or (iii) any
obligation or liability of the undersigned for profit disgorgement under Section
16(b) of the Exchange Act; and (e) this Limited Power of Attorney does not
relieve the undersigned from responsibility for compliance with the
undersigned's obligations under the Exchange Act, including, without limitation,
the reporting requirements under Section 16 of the Exchange Act.

    This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of, and transactions in, securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorneys-in-fact.

                            [Signature Page Follows]

    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 7th day of February, 2019.


                                        /s/ David Christopher Dollar
                                        ----------------------------------
                                        Name: David Christopher Dollar